New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
216.27-1.28 (-0.59%)
As of 09:52AM EDT. Market open.
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
276,771
233,912
241,214
228,424
-
Other short-term investments
-
-
1,063
1,024
941
Total cash
276,771
233,912
241,214
229,448
-
Net receivables
578,077
559,410
489,452
489,042
-
Inventory
380,259
255,809
199,146
185,695
-
Other current assets
83,378
107,580
97,311
-
300
Total current assets
1,608,662
1,439,032
1,274,095
1,201,131
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,369,079
3,018,547
2,686,989
2,388,571
-
Accumulated depreciation
-1,335,309
-1,161,130
-1,102,980
-1,085,993
-
Net property, plant and equipment
2,033,770
1,857,417
1,584,009
1,302,578
-
Equity and other investments
243,811
311,602
201,352
221,804
-
Goodwill
3,095,045
2,849,903
2,711,881
1,809,168
-
Intangible assets
864,051
955,275
1,061,192
787,599
-
Other long-term assets
309,383
148,279
151,537
75,422
-
Total non-current assets
6,586,339
6,163,738
5,750,197
4,289,700
-
Total assets
8,195,001
7,602,770
7,024,292
5,490,831
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
101
47,196
35,548
Accounts payable
168,937
205,915
198,130
122,475
-
Taxes payable
-
-
26,161
24,884
26,066
Accrued liabilities
227,825
219,758
228,797
149,820
-
Deferred revenues
241,820
264,259
219,703
250,186
-
Other current liabilities
203,210
204,575
140,436
10,675
-
Total current liabilities
1,055,082
1,091,585
1,033,185
839,751
-
Non-current liabilities
Long-term debt
2,647,147
2,707,531
2,663,564
1,900,524
-
Deferred tax liabilities
191,349
215,582
239,720
217,031
-
Deferred revenues
-
-
20,578
19,475
20,983
Other long-term liabilities
223,191
174,822
242,859
40,467
-
Total non-current liabilities
3,480,921
3,487,680
3,399,115
2,507,412
-
Total liabilities
4,536,003
4,579,265
4,432,300
3,347,163
-
Stockholders' equity
Common stock
513
509
505
498
-
Retained earnings
1,887,218
1,432,901
980,751
625,414
-
Accumulated other comprehensive income
-196,427
-262,057
-164,740
-138,874
-
Total stockholders' equity
3,596,882
2,976,293
2,534,820
2,114,602
-
Total liabilities and stockholders' equity
8,195,001
7,602,770
7,024,292
5,490,831
-